Skip to main content
×
×
Home

A review of the treatment options for clozapine-induced hypersalivation

  • Adrian Cree (a1), Shameem Mir (a1) and Thomas Fahy (a1)
Abstract
Aims and Method

To develop and introduce an evidence-based drug treatment protocol for clozapine-induced hypersalivation, a review of published literature relating to clozapine-induced hypersalivation and its treatment was undertaken in March 2000. The databases searched were Medline, EMBASE and PsychLit, from 1966 to the present.

Results

This paper reviews the evidence of the benefit of using antimuscarinic agents, adrenergic antagonists and adrenergic agonists. There is alack of good-quality controlled-trials, with most papers reporting aseries of uncontrolled cases dependent on subjective measures of improvement reported by the patients. However, the published literature suggests a benefit for all of the drug categories reviewed. The most effective treatment may be acombination of terazosin and benzhexol.

Clinical Implications

Clozapine-induced hypersalivation is not only an embarrassing problem, but can be difficult to treat. An evidence-based prescribing protocol will encourage the use of those drugs found to be the most effective in treating this problem. It will also offer alternatives if acertain treatment is ineffective or intolerable.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      A review of the treatment options for clozapine-induced hypersalivation
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      A review of the treatment options for clozapine-induced hypersalivation
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      A review of the treatment options for clozapine-induced hypersalivation
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Antonello, C. (1999) Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect (letter). Journal of Psychiatry and Neuroscience, 24, 250.
Baum, B. (1993) Principles of saliva secretion in saliva as a novel diagnostic fluid. Annals of the NewYork Academy of Science, 694, 1723.
Ben-Aryeh, H., Jungerman, T., Szargel, R., et al (1996) Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biological Psychiatry, 39, 946949.
Berlan, M., Montrstruc, J. & Lafontan, M. (1992) Pharmacological prospects for alpha 2 adrenoceptor antagonist therapy. Trends in Pharmacological Science, 13, 277282.
Calderon, , Robin, E. & Sobota, W. L. (2000) Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report. International Clinical Psychopharmacology, 15, 4952.
Copp, P. J., Lament, R. & Tennent, T. G. (1991) Amitriptyline in clozapine-induced sialorrhoea (letter). British Journal of Psychiatry, 159, 166.
Corrigan, F. M. & Macdonald, S. (1995) Clozapine-induced hypersalivation and the alpha 2 adrenoceptor (letter). British Journal of Psychiatry, 167, 412.
Fritz, J. & Tilmann, E. (1995) Pirenzepine for clozapine-induced hypersalivation (letter). Lancet, 346, 1034.
Grabowski, J. (1992) Clonidine treatment of clozapine-induced hypersalivation (letter), Journal of Clinical Psychopharmacology, 12, 6970.
Mandel, J., Zengo, A., Katz, R., et al (1975) Effects of adrenergic agents on salivary composition. Journal of Dental Research, 54, B27B33.
McCarthy, R. & Terkelsen, K. (1994) Oesophageal dysfunction in two patients after clozapine treatment. Journal of Clinical Psychopharmacology, 14, 281283.
Rabinowitz, T., Frankenberg, F., Centorrino, F., et al (1996) The effect of clozapine on saliva flow rate: a pilot study. Biological Psychiatry, 40, 11321134.
Reinstein, M., Sirotovskya, L., Chasonov, M., et al (1999) Comparative efficacy and tolerability of benzatropine and terazosin in the treatment of hypersalivation secondary to clozapine. Clinical Drug Investigation, 17, 97102.
Safferman, A., Liberman, J., Kane, M., et al (1991) Update on the clinical efficacy and side effects of clozapine. Schizophrenia Bulletin, 17, 247261.
Spivak, B., Adlersberg, S., Rosen, L., et al (1997) Trihexyphenidyl treatment of clozapine induced hypersalivation. International Clinical Psychopharmacology 12, 213215.
Ukai, Y., Taniguchi, T. & Kimura, K. (1989) Muscarinic supersensitivity and subsensitivity induced by chronic treatment with atropine and disopylfluorophosphate in rat submaxillary glands. Archives of International Pharmacodynamic Therapy, 6, 148157.
Zorn, S., Jones, S., Ward, K., et al (1994) Clozapine is a potent and selective muscarinic M4 receptor agonist. European Journal of Pharmacology, 269, R1R2.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 10
Total number of PDF views: 106 *
Loading metrics...

Abstract views

Total abstract views: 500 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 23rd July 2018. This data will be updated every 24 hours.

A review of the treatment options for clozapine-induced hypersalivation

  • Adrian Cree (a1), Shameem Mir (a1) and Thomas Fahy (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *